Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

Authors: Wolf, G.T. et al. (The Department of Veterans Affairs (VA) Laryngeal Cancer Study Group)
Source: NEJM. 1991 324(24):1685-90.
Affiliation: Ann Arbor VA Medical Center, Ann Arbor, MI.

Background

  • Prior to this landmark study, standard treatment for locally advanced (Stage III or IV) laryngeal cancer consisted of total laryngectomy +/- post-operative radiation.
  • Laryngectomy results in substantial functional morbidity (loss of voice, altered swallowing, permanent tracheostomy).
  • Pilot studies using induction chemotherapy followed by radiation demonstrated feasibility of larynx preservation with this approach
  • This study evaluated the ability to preserve the larynx without detriment to survival with induction chemotherapy and radiation instead of immediate laryngectomy.

Methods

  • Design: Randomized Phase III design (n=332)
  • Patients: VA patients with Stage III or IV squamous cell carcinoma of the larynx
    • Excluded: stage T1N1, unresectable disease, distant metastases, KPS<50, lab values that would preclude chemotherapy
  • Randomized to:
    • Induction Chemotherapy followed by definitive radiation
      • Evaluated for response after 2 cycles of:
        • CDDP (100 mg/m2) + 5-FU (1000 mg/m2 x 5 d) every 3 weeks
      • If complete or partial remission (CR or PR), then received 3 rd cycle of CDDP/5-FU and definitive RT
      • If less than PR, then underwent total laryngectomy and post-op RT
    • Immediate Laryngectomy followed by post-op RT
  • Stratification: performance status, stage (N0/1 vs. N2/3), glottic vs. supraglottic site
  • Assessment of response:
    • Physical exam and indirect laryngoscopy after 2 nd chemotherapy cycle and 12 weeks after completion of definitive radiation
    • CR: complete disappearance of visible tumor
    • PR: 50% decrease in sum of the products of longest dimension and perpendicular
    • Biopsies taken after 3 rd cycle of chemotherapy
  • Definitive radiation:
    • Primary: 66-70 Gy
    • Nodes: N0: 50 Gy; <2cm: 66 Gy; 2-4 cm: 70 Gy; >4 cm: 75 Gy
  • Post-operative radiation:
    • Normal risk microscopic: 50 Gy
    • High risk: 60 Gy
    • Presumed residual: 65-73 Gy
  • Surgery:
    • wide-field total laryngectomy except rare cases where a horizontal partial laryngectomy could be performed
    • neck dissection: all except T3N0 and midline supraglottic T4N0 where side could not be determined
    • Median follow-up was 33 months (range, 11 to 62 months)

Results

  • Groups were well-balanced and represented typical VA population with larynx cancer (80% white, 97% male, 99% smokers, 85% drank alcohol)
  • Responses after chemo:
    • CR 31% (2 cycles); 49% (3 cycles)
    • PR 54% (2 cycles); 49% (3 cycles)
  • Pathologic complete responses after definitive RT
    • 88% of clinical CR, 45% of clinical PR
  • Response did not predict overall survival
  • Of the deaths, most died from cancer
    • 8 patients (2%) died during treatment
    • 3/8 surgical complications
    • 1/8 related to chemo (neutropenic septicemia)
  • Overall survival was identical: 68% at 2 yr (p=0.98)
  • Disease-free survival was non-significantly worse in induction chemo arm (p=0.12)
  • Larynx preservation: 64% chemo arm, 0% surgery arm
  • Relapse patterns differed, but overall rates did not:
    • Local: 2% surgery arm, 12% chemo arm
    • Distant: 17% surgery arm, 11% chemo arm
  • Salvage laryngectomy:
    • 30 patients:
      • 19 for persistent disease at 12 week re-evaluation
      • 11 for recurrence
      • required more often in patients with Stage IV disease (p=0.048) and T4 disease (0.001)

Discussion

  • Larynx preservation could be achieved in 64% via induction chemotherapy followed by definitive radiation in locally advanced larynx cancer
  • This was accomplished without a decrement in overall survival
  • Patterns of relapse differed: more local failures and fewer distant failures in chemo arm compared to surgery arm

Author's Conclusions

This was a landmark study that established the possibility of larynx preservation in locally advanced laryngeal squamous cell carcinoma

Epilogue:

  • Overall survival at 5 and 10 years, chemotherapy-treated group was 5% less than the surgical arm (difference not statistically significant)
  • Quality of life was better in chemo arm
  • RTOG 91-11 showed that concurrent chemoradiation superceded induction in terms of laryngectomy-free survival and time-to-laryngectomy

Criticisms and Pertinent Questions:

  • The concept of "organ preservation" is not as important as "functional organ preservation."
  • The success rate of late salvage laryngectomy after induction chemo and RT was not described in this paper
  • Does lack of response to chemotherapy predict a poor response to radiation?
  • Could some of these patients have been cured with radiation alone?

OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.


Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania